The size of the Ultrasound devices market in the Middle East and Africa has been estimated at USD 398.43 Million in 2022 and is projected to reach USD 504.89 Million by 2027, growing at a CAGR of 4.85% from 2022 to 2027.
An increase in the prevalence of chronic diseases such as cardiovascular disease, diabetes, cancer, and other diseases is driving the ultrasound devices market in the MEA region. For example, cancer is the most common cause of death in the UAE is due to the constant changes in lifestyle, eating habits, physical inactivity, obesity; the increase in the aging population and other health conditions will result in the adoption of effective diagnostic and treatments that are expected to accelerate the market growth.
Furthermore, the increase in the initiatives and investments from government and non-government in ultrasound imaging is expected to encourage market growth. The market is divided into various types of imaging such as 2D ultrasound imaging, Doppler imaging, high intensity focused ultrasound, and many others as ultrasound provides speedy and accurate diagnoses with no pain and no contact with ionizing radiation.
The growing various types applications of its expanding use of new technologies are raising the demand for the market growth. In addition, the increase in the latest advancements and development in the technology for advanced devices such as portable or compact ultrasound devices, which are more convenient to use, with the rise in the demand for minimally and non-invasive diagnostic procedures. Moreover, the increase in the awareness and adoption of the system during emergency cases in clinics, hospitals, and other institutions is fuelling ultrasound devices' growth in the Middle East and Africa.
However, lack of skilled and trained individuals for performing the techniques as these techniques require anatomical knowledge as, over time, the ultrasound devices have become more sophisticated. Also, the issues resulted with age; spine imaging becomes complex and challenging in older people as the bones block the ultrasound waves. In addition, the stringent rules and regulation of government policies for product approval affect the growth of the MEA ultrasound devices market.
This research report on the Middle East and Africa ultrasound devices market has been segmented and sub-segmented into the following categories:
By Device Display:
Geographically, the Middle East and Africa market is projected to witness a substantial share in the global ultrasound devices market during the forecast period. The market growth is attributed to the increase in the prevalence of chronic diseases, the rise in infectious diseases among the people in the region. In Addition, the growing adoption of ultrasound devices for better imaging and accuracy in diagnosing is expected to expand the market growth. Furthermore, lung cancer is the deadliest disease, and new cases among people in the region significantly contribute to the ultrasound market growth.
In further years, lung disease is estimated to be the top five most common diseases in South Africa. The UAE recorded 4,500 new cancer cases every year, leading to the region's third most common cause of fatality. And with the help of raising awareness, initiatives, and fundings from the government and non-government firms for research purposes. UAE aims to reduce cancer fatalities in the upcoming years with the help of good health, well- being and government support.
The Saudi Arabian ultrasound devices market is also expected to have impressive growth due to the new developments and advancements in the technology with rising in the advances in the applications of the ultrasound devices and by inducing new market strategies for expansion of the market, driving the growth of the ultrasound devices market.
KEY MARKET PLAYERS:
A few of the promising companies operating in the MEA ultrasound devices market profiled in this report are General Electric Company (U.S.), Koninklijke Philips N.V., Toshiba Corporation, Siemens AG, Hitachi Ltd., Samsung Electronics Co., Ltd., FUJIFILM Holdings Corporation, Esaote S.p.A., Mindray Medical International Ltd and Analogic Corporation (U.S.).
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org